wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35051306-31FFAFD2-0151-497A-9E18-68D273767650
Q35051306-31FFAFD2-0151-497A-9E18-68D273767650
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35051306-31FFAFD2-0151-497A-9E18-68D273767650
Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing state.
P2860
Q35051306-31FFAFD2-0151-497A-9E18-68D273767650
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35051306-31FFAFD2-0151-497A-9E18-68D273767650
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6f11af205cd7525420fdc1080229e6ddbcd7f452
P2860
Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.